Akynzeo 300-0.5 MG capsules
Ended Awarded Last action
- Contract number
- SPE2DR26F9GC5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,519
Award facts
- Contract value 100% obligated
- $43,519.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,519.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AKYNZEO 300-0.5 mg capsules, a pharmaceutical product used to prevent chemotherapy-induced nausea and vomiting. This non-set-aside competitively awarded contract has an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle that enables the company to supply pharmaceutical products to federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply chain. The company holds a significant indefinite delivery contract valued at $999,999,999.00 with the DLA Troop Support Medical (SPE2DX) through December 2026, which provides the framework for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls within that broader pharmaceutical support vehicle and reflects AmerisourceBergen's established capability to fulfill federal procurement requirements for specialized medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9GC5?
SPE2DR26F9GC5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F9GC5 worth?
The government has obligated $43,519 on SPE2DR26F9GC5.
Is contract SPE2DR26F9GC5 an order under another contract?
Yes. SPE2DR26F9GC5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GC5 competed?
The extent of competition for SPE2DR26F9GC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award